Johnson & Johnson Earnings: Pharmaceutical Sales Again Lead the Way – Motley Fool


Motley Fool
Johnson & Johnson Earnings: Pharmaceutical Sales Again Lead the Way
Motley Fool
Even though its consumer products and medical device and diagnostic segment combine for more in total sales than its pharmaceutical segment, the margins in its pharma segment absolutely trounce that of the other two, making it by far J&J’s cash cow.
Johnson & Johnson: Q3 Results Show Rapid US Pharmaceutical Growth, But Seeking Alpha (registration)
J&J hikes 2014 forecast for a third timeGreenwich Time
J&J says it expects higher earningsAsbury Park Press

all 173 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd